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ABSTRACT. This paper investigates the processes by which scientific 
knowledge is created and legitimized. It focuses on scientific developments 
in a branch of medicine and explores the pathways through which the 
growth of knowledge enables advances in medical science and in clinical 
practice. This work draws conceptually on evolutionary approaches to 
technological change. The empirical part presents a longitudinal analysis of 
a database of scientific publications in the field of ophthalmology over a 
period of 50 years. Such an exercise allows us to identify pathways of shared 
understanding on a disease area, and to map out distinctive trajectories 
followed by the ophthalmology research community. The paper also 
contributes to general understanding of the innovation process by 
supporting the notion that knowledge coordination is a distributed process 
that cuts across and connects complementary areas of expertise. 
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1. Introduction 
This paper investigates the processes that stimulate and facilitate 
the creation and legitimization of scientific knowledge. It is focused 
specifically on the emergence and the diffusion of new medical 
understanding and of clinical know-how. 
The conceptual foundations of this work are located in the vicinity 
of the Austrian school of economics. In this view individuals’ private 
knowledge can be connected with – but never identical to – the 
knowledge of others (Loasby, 1991; Metcalfe and Ramlogan, 2005; 
Shackle, 1992). This puts learning and communication activities at the 
core of the process of knowledge growth. An important caveat, 
however, is that both these activities rely on individuals’ perceptions 
and representations of private knowledge and are therefore prone to 
imperfections. From this it follows that private knowledge contributes 
to collective action insofar as interactions across individuals are 
coordinated through rules that stimulate shared understanding. 
The paper casts these issues in the context of medicine with a view 
to exploring the mechanisms through which scientific understanding 
about human diseases grows over time. It proposes an empirical study 
of progress in the diagnosis of glaucoma informed by an historical 
overview and complemented by a longitudinal analysis of scientific 
publications over a period of 50 years. The observed expansion in the 
ecology of ophthalmology journals delineates distinctive trajectories 
followed by the research community and indicates the emergence of 
pathways of shared understanding on glaucoma. The resulting maps 
are a novel methodological contribution to innovation studies in that 
they synthesize the dynamics of generation and use of knowledge. The 
broader point that emerges from this analysis is that the growth of 
scientific understanding unfolds along sequences of problems and 
solutions which draw on and impinge upon an expanding knowledge 
base. Such a process requires increasing variety not only in the content 
of scientific knowledge but also in the standards for its dissemination. 
The paper contributes also to the field of innovation studies. Our 
probe of medical research highlights two crucial conditions under 
which new knowledge stimulates innovative activities, namely variety 
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in the forms of specialization and the coordinating role of institutions 
(Loasby, 1999; Nelson, 2002). In so doing it supports the notion that 
knowledge coordination is a distributed process that cuts across and 
connects complementary realms, namely the organization of scientific 
research, the design of regulatory rules, the evolution of communities 
of practitioners, the delivery of services (i.e. patient care) and the 
creation of new market processes (Metcalfe et al, 2005; Mina et al 
2007; Consoli and Mina, 2007). 
The paper is organized as follows. Section 2 presents the 
conceptual background and casts the dynamics of knowledge in the 
realm of medicine. Section 3 presents the empirical analysis with an 
overview of the glaucoma disease and the network analysis of relevant 
scientific work in the ophthalmology community. The last section 
discusses the main findings and summarizes. 
2. Innovation and the growth of knowledge: the building blocks 
The first part of this section introduces the conceptual framework 
and is followed by an articulation of several key themes germane to 
the empirical domain of medicine. 
Scholarly literature on economics of innovation argues that 
economic development is an evolutionary process driven by the 
growth of knowledge in historical (real) time (Dosi, 1988; David, 
2001; Loasby, 1991; Nelson, 1995; Antonelli, 2001; Metcalfe, 2001). 
Works in this tradition highlight three general features of economic 
action: (i) the cyclical emergence of problems – or bottlenecks, or 
reverse salients; (ii) the concentration of efforts and development of 
specific expertise towards the formulation of possible solutions; and 
(iii) the implementation of such solutions, which typically involves 
mutual adjustments between the micro-behaviours of the agents and 
the macro-characteristics of their environment. 
The evolutionary approach submits that economic agents are 
boundedly rational, and can therefore generate and exploit new 
knowledge only within limited domains and circumstances. The 
primary reference here is the Austrian school of thought which first 
suggested that individuals’ problem-solving ability is circumscribed 
by natural cognitive constraints (Shackle, 1992; von Hayek, 1945; 
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Loasby, 1991, 1998; Ziman, 1978). Decision-making in this view is an 
emerging feature rather than ex-ante prerogative, and it reflects how 
economic agents strive with learning, applying and communicating 
knowledge. Metcalfe and Ramlogan (2005) emphasise that all such 
processes are prone to imperfections because knowledge is a 
characteristic of individuals’ states of mind and as such is not 
accessible by anybody else. Instead, they argue, private knowledge 
materializes in practical applications and can only be enriched through 
exposure to others’ representations of individual knowledge. In other 
words private knowledge can be connected with – but never identical 
to – the knowledge of others. In turn, private knowledge contributes to 
collective problem-solving through shared rules of interaction. 
Metcalfe and Ramlogan propose the notion of ‘understanding’, a 
socially distributed process that shapes and directs the communication 
of private knowledge across individuals through languages, rules of 
behaviour and shared legal and social settings.1 
Building on such conceptual premises, evolutionary approaches 
advance two important propositions. First, the growth of knowledge is 
a path-dependent process which develops along trajectories of 
technical and procedural understanding (Dosi, 1988; David, 2001). 
Second, the efficacy of new knowledge depends on the feedbacks 
generated by its application in relation to specific problems. Social 
understanding is central both for the accumulation and the 
recombination of knowledge. In turn, when the growth of knowledge 
spans different boundaries innovation (viz. effective problem-solving) 
is characterised like a collective process that draws on and impinges 
on a variety of sources (Antonelli, 2001; Kogut and Zander, 2003). 
Let us now cast these themes in the analysis of medical innovation. 
                                                 
1 As Metcalfe and Ramlogan (2005: 658) put it: “We can never say two individuals have the 
same knowledge, nor devise a way of establishing what they know. We can say instead that as 
individuals they have the same understanding in so far as they provide indistinguishable or at 
least closely correlated answers to the same question or if they respond in indistinguishable 
ways to the same instructions”. 
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2.1 – The growth of medical knowledge 
The importance of understanding how progress comes about in the 
field of medicine can hardly be overestimated if one considers the 
implications on human and social well-being. The archetypal 
approach in health economics and health-care management is based 
on a rather simplified model which holds scientific breakthroughs as 
the key source of new medical technologies, and portrays the route 
through to adoption and use as a linear process divided into discrete 
steps, namely Applied Research, Targeted Development, and 
Manufacturing & Marketing.  
Along with recent contributions in this field, we argue that being 
built on mistaken foundations linear approaches proffer a limited 
interpretation of medical innovation, especially vis-à-vis empirical 
evidence on the complexities of scientific research and health-care 
provision (see Gelijns and Rosenberg, 1994; Gelijns et al, 2001). First, 
by assuming that the link between R&D and technology adoption is 
one-way, they neglect the instances in which medical devices are 
modified to accommodate informed feedback generated by end-users 
(Von Hippel, 1976, 1988). Second, as Rosenberg (1974) makes clear, 
the development of science and technology is embedded in specific 
contexts of use that shape the direction and the timing of invention. 
Unevenness across the pathways of learning in different areas of 
expertise generates different cost structures and, a fortiori, uncertainty 
in the adoption and development of new technologies (Nelson, 2003). 
In the medical realm this is especially frequent when General Purpose 
Technologies, such as lasers and electronics, are transferred into the 
clinical setting. A third, and more cogent objection is that linear 
models suggest that scientific developments are primarily the result of 
deductive methods aimed at the construction of theories or the 
solution of theory-generated problems. But accepting that theory-
building is the prime goal of scientific research implies that applied 
sciences are derivative and, thus, that they lack distinctive patterns of 
cognitive development. Neither of these statements seems pertinent to 
mission-oriented sciences. The history of medicine, in particular, 
shows that theoretical, methodological but also philosophical 
constrains may prevent the formulation of some research assumptions 
or the selection of specific routes of investigation. This is so because 
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the production and legitimation of medical knowledge is embedded in 
the long-term development of individual disciplines and reflects the 
social relevance that is attached to health problems at specific points 
in time (Amsterdamska, 1987; Blume, 1992; Geljins et al, 2001). 
Equally relevant is the point that the design and implementation of 
medical solutions involve integration of knowledge via changes in 
work practices and relationships. Clearly such processes bear upon 
interest groups – i.e. professional and organizational – which feature, 
as Rosenberg (1974) reminds us, different cost structures. 
This paper takes the view that medical innovation is a long-term 
learning process, and explores the notion that the diffusion of new 
scientific conjectures rests on two complementary conditions: growth 
in the ecology of forms of knowledge and the creation of coordination 
mechanisms. In so doing it highlights the role of learning pathways 
across scientific research and clinical practices, a connection which is 
arguably over-simplified in the context of linear models. The paper 
argues that the selection and formulation of medical problems is 
shaped by theoretical conjectures and practical problem-solving alike. 
In so doing it suggests that problem-finding and problem-solving 
belong to complementary dimensions, and that their relative 
contribution to scientific knowledge depends on the efficacy of the 
institutional conduits that support Health Innovation Systems. While 
we deem impracticable to establish a priori causations in the dialogue 
between scientific and clinical domains, we propose an analysis that 
attempts to disentangle the learning pathways that are embedded in 
scientific problem-choice and problem-solving. 
Figure 1 shows a stylised representation of a health system. This is 
divided in domains of activities, or ‘gateways’, and connected across 
through channels of interaction, or ‘pathways’ (Consoli and Mina, 
2007; Consoli and Ramlogan, 2008). 
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Figure 1.  Gateways and Pathways in a Health System 
The hypothesis that such systems feature different ecologies of 
expertise and domains of influence is useful to the effect of 
accounting for the diversity of knowledge involved in health-care. 
Thereby, gateways correspond to sub-components domains such as 
the patient-practitioner relation; the system for the provision of patient 
services (i.e. consultation, diagnosing, choice and therapy) and of 
medical training; the system of production for medical devices and 
drugs; the supervisory role of regulation. At the same time the 
evolution of medical practice involves interactions both within and 
among the foregoing domains: their instituted coordination through 
pathways marks the transition from ecology of agents to system 
(Metcalfe et al., 2005). The emergence of pathways in a system 
reflects both the application of knowledge into specific activities, and 
the exchange of information across the gateways (Consoli and Mina, 
2007). Different from linear models of medical innovation, the 
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directionality of pathways does not confine the potential of innovation 
only to scientific breakthroughs but calls for appreciation of multiple 
sources across all domains. 
It is worth mentioning that the importance of variety in a system of 
innovation thus defined draws attention on the coordinating task of 
institutions. Following Loasby (2001) we take the view that scientific 
progress requires a clearly defined system of understanding to 
circumscribe the space in which solutions are searched. The notion of 
pathways presented here accounts for a purposefully broad view of 
institutions, one that includes formal and informal processes aimed at 
facilitating the coordination of learning across a variety of interest 
groups – i.e. gateways – within a health-system. Pathways are, we 
argue, prime drivers for the growth of medical knowledge and 
innovation. The synthesis of the dynamics of Health Innovation 
Systems based on such heuristic notions opens up promising 
methodological avenues. This view draws primarily on empirically-
informed observations and seeks to disentangle how health problems 
come to the attention of the medical community; how their scientific 
understanding evolves over time; and how they are ultimately 
translated into clinical solutions. The empirical part of the paper will 
cast these themes in the context of a specific area of medical research. 
2.2 – Health Systems and Problem Sequences 
Reflecting back on the opening statement, that medical innovation 
involves long-term learning, we focus on the processes that contribute 
to the growth of scientific understanding and the complementary role 
of institutional pathways for the diffusion of scientific ideas. Echoing 
the evolutionary approach outlined earlier, we take the view that 
innovation represents a systemic response to the emergence of 
problems in a set of prevailing practices. This process begins with the 
search for alternatives and experimentation and, if successful, leads to 
the emergence of novel ideas that challenge existing knowledge and 
the prevailing system of understanding. Innovations, however, can be 
rarely if ever pinpointed to a single point in time, or ascribed to 
isolated sources of knowledge. Innovation comes about through 
trajectories of improvement sequences in which procedures are 
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progressively refined and extended in their scope of application. This 
process is incremental, it unfolds over time and it implies that as old 
problems are solved new ones range into view. The latter, in turn, 
form new foci for innovative effort within the broad objective to 
improve the efficacy of the extant procedure. Furthermore, by 
extending the range of application and improving practice, solutions to 
medical problems challenge the boundaries of scientific understanding 
and contribute to reshape them.  
Our conjecture is that a process thus defined consists in the 
exploration of a design space, unfolding in a largely path-dependent 
fashion within bounds set by the perception of the problem (Metcalfe 
et al. 2005). Accordingly, the accumulation of medical knowledge 
occurs along trajectories of change that emerge over time in the 
search for better and better solutions to clinical problems (Metcalfe et 
al. 2005; Mina et al. 2007; Consoli and Ramlogan, 2008). Such 
trajectories emerge in the form of sequences of innovative ideas, 
reflect coherent directions of change and signal the cumulativeness of 
research activities whose results build on previous knowledge. These 
involve also the creation of formal and informal standards (Utterback, 
1994) to support the search for novel solutions. 
The emergence of such trajectories also implies that the evolution 
of knowledge is not random but rather driven by guided search within 
defined design spaces (see Dosi, 1988; Loasby, 1991). In other words, 
the direction of progress can very rarely be seen ex ante meaning that 
there is little room for determinism in the emergence of trajectories. 
Research paradigms thus understood are complex processes shaped by 
the experiences, the competences and the visions nurtured within 
communities of practitioners. 
As already anticipated, the power of theoretical understanding is 
severely circumscribed in those areas of medicine in which practice 
and experience come to play a bigger role. The notion of problem 
sequence captures the idea that the search for solutions in a design 
space spans a variety of areas of expertise be they clinical, medical, 
organizational or entrepreneurial. In this view each innovation implies 
the embodiment of individual knowledge in the design of medical 
solutions. For the very same reason innovation sequences can halt 
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when the problems are beyond knowledge and imagination and await 
some breakthrough, possibly in an unrelated body of knowledge. 
The overarching proposition that emerges from these observations 
is that the growth of medical knowledge and its application into 
changing design spaces fuel the evolution of open systems of 
scientific understanding. To show this, and taking our cue from the 
conceptual points discussed before, we focus the empirical analysis on 
the activity of the scientific community. In terms of Figure 1 we will 
thus concentrate on the learning pathways in the upper part of the 
diagram. Scientific and medical communities are important to the 
effect of catalyzing experiences, exploring alternatives, and designing 
new clinical solutions. As Langlois and Savage (2001) show, their 
organization relies on professional networks that are coordinated by 
means of formal and informal standards. In the next section we will 
focus specifically on scientific publications whose function is to 
provide a standard for the dissemination of ideas both within research 
communities and between the latter and other domains such as clinical 
practice or the market (Shryock, 1974; Weisse, 1991).  
3. Empirical case study: Glaucoma 
This section presents an empirical study on the dynamics of 
medical knowledge in a specific disease area, namely Glaucoma, and 
is organized in two subsections. The first introduces the nature of the 
medical problem and highlights the changing boundaries of scientific 
understanding of the disease. The following subsection integrates this 
overview with a network analysis of a database of publications in 
scientific journals with a view to disentangle the pathways of learning 
observed in the context of the ophthalmology research community.2 
 
                                                 
2 For a more detailed version of the case study on glaucoma see Consoli and 
Ramlogan (2007). 
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3.1 – Background and overview 
Glaucoma is a chronic disease of the optic nerve which, if 
untreated, eventually causes blindness. Global prevalence of the 
disease is estimated at 50-70 million, of which 7-8 million finally 
suffer total blindness (Source: Glaucoma Foundation3). Damage 
caused by glaucoma can be slowed or arrested, but not reversed: 
patients affected by glaucoma experience progressive impairment of 
visual field as damage to the optic nerve advances.4 Despite 
abundance of theories the pathogenesis and the development of this 
disease have not been clearly identified yet.5 Progress in diagnostics 
has brought about various techniques to detect the onset of glaucoma, 
but the connection between the degenerative process in the structure 
of the eye and loss of vision has not been fully clarified. If anything, 
more accurate research has reinforced the notion that glaucoma is a 
complex disease, and that ophthalmology has still a limited grasp of 
the connections among causes and symptoms. 
A quick look at the history of ophthalmologic research and practice 
highlights two phases of scientific exploration. The first (1880s-
1960s) is characterized by the dominance of the Intra-Ocular Pressure 
paradigm which has shaped research efforts and the creation of 
important diagnostic techniques but has also led to blind avenues. 
Refutation of the latter conjecture is the thrust of the second phase 
(1970s-2000s) in which the research community has explored 
increasingly diverse routes of investigation. 
The clinical diagnosis of glaucoma in the early days was based on 
the interpretation of symptoms of the glaucomatous eye, usually 
swollen and congested. Accordingly, the prevailing diagnostic 
techniques were based on the observation of the iris, which regulates 
the entry of light in the eye similar to the aperture of a camera. In this 
area is found an aqueous humor which has the important role of 
                                                 
3 http://www.glaucomafoundation.org/ 
4 The optic nerve plays a fundamental role as it connects the eye to the brain. 
5 A comprehensive, yet accessible also to non-practitioners, overview of the state-of-
the-art in research on glaucoma can be found in the authoritative article by Quigley 
(2004). 
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bathing the lens and the cornea. The pressure of this fluid, Intra Ocular 
Pressure (IOP), regulates the nourishment of the optic nerve which is 
in the inner part of the eye. It is well known that elevated pressure can 
obstruct the microcirculation of blood and, in turn, if blood does not 
properly nourish the optic nerve some of its tissues die causing an 
excavation, known as ‘cupping’. The prevailing scientific 
understanding of glaucoma until the mid-1950s was based on the 
notion that glaucoma is solely associated to abnormal levels of IOP. 
The guiding heuristic for the design of early diagnostic techniques 
sought to enhance visualization of the inner part of the eye and to 
achieve reliable measurement of IOP. The standard instrumentation in 
an ophthalmologist studio in the first half of the 1900s included direct 
and indirect techniques (Consoli et al, 2005). Among the former were 
visualization tools such as the ophthalmoscope, to observe the optic 
nerve; the funduscopy to examine the back of the retina through a 
dilated pupil; and the gonioscope, a variation of the former two 
techniques used to scrutiny the anterior chamber of the eye. These 
were used together with the tonometer, an instrument to measure the 
eye pressure which featured two basic variants (e.g. indentation and 
applanation). Direct techniques seek to provide an objective 
assessment of the structural feature of the eye. Indirect ones, such as 
perimetry, instead are based on the collaboration of the patients who is 
required to report on perceived alterations of the visual field. This 
particular technique which was originally developed in the context of 
patient care and later used for laboratory research, offers a clear 
example of the flawed logic of linear models. In fact, the design of 
most of such instruments went through significant changes as a result 
of the interplay between scientific research and clinical care, also 
aided by the assimilation of new sophisticated technologies for digital 
imaging (i.e. Scanning Laser Ophthalmoscope, Scanning Laser 
Polarimetry) and digital measurement (i.e. Electronic Indentation 
Tonometer). 
Beginning the 1960s the notion that glaucoma manifests itself 
homogeneously had been abandoned following empirical evidence 
that pointed to three major forms of the disease: primary open angle 
glaucoma (POAG), primary acute closed angle glaucoma (PACG) and 
primary congenital glaucoma (PCG), as well as a few others 
associated with developmental abnormalities (Duke Elder, 1959). The 
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discovery of POAG is particularly important for the future of 
ophthalmologic research because it showed that disease is not always 
related to abnormal IOP levels. Interestingly, this new conjecture 
started in the clinical setting and not in theory-based work, and fuelled 
several epidemiological (i.e. population-based) studies which 
confirmed that glaucoma is a demographically-selective disease. The 
Collaborative Glaucoma Study, the Beaver Dam Study and the 
Baltimore Study among others, collectively contributed to a detailed 
picture of the incidence of glaucoma according to age, racial 
background, existence of glaucoma in family history or the co-
presence of heart diseases. These studies also revealed important 
differences between the Open Angle Glaucoma (OAG) and Angle 
Closure Glaucoma (ACG), although the majority of studies have been 
concerned with ‘definite cases’ of Primary OAG. 
Such a broader understanding of the disease coupled with the only 
partial success of existing techniques led the scientific community to 
explore new routes and to intensify clinical-based work. As Nelson 
(2005) has often noted, this kind of turn of events is typical of 
practice-based sciences, for the ability to provide effective solutions to 
medical problems does not always imply synchronism between 
scientific understanding and the prevailing forms of clinical practice. 
Rather, these will probably advance at an uneven pace. 
The following phase of scientific research in the 1970s followed 
the conjecture that glaucoma can be assimilated to some form of 
neuropathy, and tested through diagnostic scanning of physical 
changes in the optic disc (see discussion in the following section). 
Subsequently as the notion that disc changes are always a factor in 
glaucoma patients was undermined, attention shifted to the diverse 
manifestations of the disease, and its changing degrees of intensity 
across patients. Other than reaffirming once more the partial 
inadequacy of existing diagnostics, it became clear that the correct 
interpretation of individual features of each patient may lead to early 
detection of glaucoma, even before any damage occurs. To this novel 
direction of research are associated novel diagnostic techniques – like 
the Retinal Nerve Fibre Layer (RNFL) assessment – based on the 
examination of factors that are independent from changes in the optic 
disc. These issues mark a clear step in the direction of modern genetic 
investigation. The discovery of the genetic cause associated to 
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glaucoma in 1994 has radically altered the course of research and 
stimulated cross-fertilization of ophthalmology with specialist areas 
like molecular biology and genetics.  
It is now clear that glaucomas (now commonly used in the plural 
form) are a heterogeneous group of eye conditions with manifestation 
from early in life to late age and with different genetic bases. 
Interestingly enough, though the unitary association between IOP and 
glaucoma has been challenged for some fifty years, treatment is still 
largely based on the variants of the IOP-lowering axiom with the 
recent addition of laser surgery. This is so because elevated 
intraocular pressure remains the most easily treatable factor. In fact, 
greater specialization in pharmacotherapy has brought about a spur of 
alternatives like selective and nonselective β-blockers and inhibitors. 
As a consequence, prescribed regimens have now evolved into 
patient-specific combinations of these medications. New research is 
seeking to operationalize improved understanding on the aetiology of 
glaucoma and to generate therapies for those cases that cannot be 
treated with IOP-lowering techniques. The field of gene therapy holds 
great promises and is expected to trigger significant advances, though 
the practical implementation of this type of treatment is still at its 
infancy. Again, it seems clear that advancements in basic research (i.e. 
genetics) proceed unevenly with respect to practical applications that 
may be implemented. 
Summing up, scientific progress in glaucoma indicates that despite 
many advances key questions about this disease still loom large: can 
glaucoma be detected with certainty? Can it be cured? If so, how? 
Such, we surmise, is the nature of progress when the problem is 
inaccurately specified, or too complex to understand given the 
prevailing knowledge base. 
3.2 – A network analysis on Glaucoma research 
In this section we use network analysis to highlight the pathways 
of learning within the glaucoma scientific community. The primary 
source is a database of bibliographic information of over 13,000 
scientific articles about glaucoma over the period 1945 to 2003 drawn 
by the authors from the ISI Thompson online resources. To parse the 
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data we developed a Perl script and implemented it within the Pajek 
software.6 In particular, we employ the idea of the main path 
algorithm that is incorporated into Pajek (Batagelj, 2002). This 
method was first proposed by Hummon and Doreian (1989) in their 
analysis of the development of DNA theory.  In that paper and in a 
subsequent study of the literature on measures of centrality in social 
networks research (Hummon and Carley, 1993) distinctive pathways 
through the respective citation networks were found to be related to 
the key intellectual developments that defined the respective fields 
(see also Carley et al., 1993).7 
The main path captures a structural feature of a network that 
contrasts with the orthodox approaches such as bibliometric coupling 
or co-citation, used for studying structure, in that these latter 
approaches focus on the clustering of nodes. The novelty Hummon 
and Doreian proposed is to make use of the links of the network rather 
than the nodes, that is, on the network’s connectivity. Thus the 
algorithm captures what is referred to the ‘structurally determined 
most-used path’ in a network; it is the path with the highest traversal 
counts (Batagelj and Mrvar, 1998), measured by the number of times 
that a tie or link between articles is involved in connecting other 
articles in a citation network (Hummon and Doreian, 1989).  The main 
path analysis thus analyses all possible search paths through the 
network starting with an origin article through to endpoint articles, 
and calculates the traversal counts of each link in the network.  
Figure 2 shows the main path emerging from our network of over 
300,000 nodes made up of the primary references and their citations.  
The algorithm selected the connections between these 43 nodes as 
being the most important in the network and interestingly, as we 
discuss below, they synthesise the brief journey in the history of 
glaucoma research outlined previously.8 
                                                 
 6 Pajek is software developed for network analysis provided freely for academic use 
on http://vlado.fmf.uni-lj.si/pub/networks/pajek/. 
7 Besides the authors’ cited works, other innovation scholars have recently employed 
this method to analyze patent citations on fuel cell research, e.g. Verspagen (2007), 
and data communication standards, e.g. Fontana et al (2008). 
8 It is not possible to visualize the entire network. For our purposes we capture and 
display essential aspects of it. In this respect although main path connections are 
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Figure 2. The main path of Glaucoma research 
The graph is organized temporally starting with some of the earliest 
citations in the 1930s and finishing at three papers which represent the 
end point of the study. The nodes connected to Feldman (1969) at the 
bottom of the diagram represent the IOP paradigm discussed earlier. 
Subsequently, Drance and Begg (1970) and Begg et al (1971) put 
forward the hypothesis that glaucoma is a neuropathy. In the 
following decade the path-breaking work by Airaksinen and Tuulonen 
(1984) finally refuted the idea that optic disc changes are always a 
factor in glaucoma, and highlighted that the pathogenesis of the 
disease differs to a substantial degree. Finally, Høvding and Aasved 
(1986) established the impact of family history on glaucoma patients. 
                                                                                                                   
presented in a linear fashion, the reader is warned not to represent the process as 
linear. In fact the trajectory of the main path meanders across the glaucoma search 
space and the layout of the map is just a convenient way to compact the journey. 
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This confirms the historical background discussed in the previous 
section, and points to the emergence of new scientific understanding 
which later paved the way to genetic-oriented studies on glaucoma, 
located in the upper part of the main path diagram. The works of 
Sarfarazi (1997) and Ray et al (2003), in particular, inform on the 
recent spur of techniques seeking to map various types of glaucoma in 
relation to specific genetic mutations. 
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Figure 3. Glaucoma Journal Population 
So far individual papers have been used as unit of analysis. Let us 
now shift the focus slightly. Figure 3 provides a breakdown of the 
ecology of scientific journals in our dataset and confirms the tendency 
towards greater variety: beginning the 1970s almost half of the articles 
on glaucoma have been published on journals whose scientific scope 
falls outside the traditional boundaries of Ophthalmology, and span 
diverse areas of medicine. 
Subsequently, if we use a variation of the main path algorithm and 
focus on journals as the unit of analysis, can we capture the changing 
pathways from a network perspective? To answer this question we 
recoded our data to illustrate the significance of the non-traditional 
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journals. Figure 4 shows the journal-journal citation network 
obtained.9 
 
Figure 4. Longitudinal Analysis of the Network 
 
This diagram provides two overriding indications. First, there is a 
clear pathway from the early period, 1945, through to 2003. Second, 
and more importantly, the network of citations features a ‘broadening’ 
in the upper part with several non-traditional journals that now make 
up the ophthalmology ecology. These include Pharmacogenomics, 
Molecular Brain Research, Molecular Vision, Journal of Biological 
Chemistry, Human Molecular Genetics, Journal of Medical Genetics. 
This development roughly corresponds to what had been observed in 
                                                 
9 We limit the amount of nodes in this diagram to 235 and label only selected 
journals to improve the readability of the map. 
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the main path of the papers in Figure 2. Interestingly, these branch out 
from the main path of traditional journals such as British Journal of 
Ophthalmology, American Journal of Ophthalmology and Archives of 
Ophthalmology.10 
Recall that earlier we raised the point that scientific publications 
represent a de facto standard for the coordination of information 
exchange within and across scientific communities. Professional 
scientific journals have long been recognised as being a vital channel 
in the communication system of contemporary science (Ziman, 1968). 
In the field of Scientometrics, journal-journal citations are widely used 
to indicate changes in science. Such networks provide a rich domain 
to observe the emergence and death of individual units and clusters of 
journals at various levels of aggregation, that is, journal mappings can 
be used to indicate changes in science (Leydesdorff, 1994, 2003). 
Taking technological breakthroughs in natural sciences as empirical 
probes, Leydesdorff and various coauthors (Leydesdorff & Gauthier, 
1996; Van den Besselaar & Leydesdorff, 1996) concluded that new 
developments can be traced in terms of the being cited patterns of 
journals. New developments attract attention by scholars in 
neighboring fields and therefore journals reporting on these new 
developments are cited to a significantly larger extent than in a 
previous year. 
In sum, taking journals as a unit of analysis enables us to reflect on 
the observation that as knowledge grows the design space expands 
qualitatively in that it involves the cross-fertilization of different areas 
of scientific expertise. In turn, we see the expression of this in the 
form of additions to the ecology of journals related to a specific 
problem, such as glaucoma. We argue that the proliferation of this 
particular professional standard is one of the signatures of the 
emergence of new branches of sub-specialization. Tracking journals 
helps us to capture emerging pathways among the different research 
communities to a greater degree than individual papers (see Metcalfe 
et al, 2005; Mina et al 2007; Consoli and Mina, 2007; Consoli and 
Ramlogan, 2008; Ramlogan et al, 2007). 
                                                 
10 Journals were classified as tradition or non traditional according to whether the 
word ophthalmology (in English or otherwise) appeared in their title. 
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4. Concluding Remarks 
This paper has investigated the processes by which scientific 
knowledge is created and legitimized. More specifically, it has 
focused on a branch of medicine with a view to exploring the 
pathways which enable the emergence and the diffusion of new 
medical understanding and its translation into effective clinical 
practice. 
The paper explored the idea that medical innovation is a long-term 
learning process, and that the diffusion of new scientific conjectures is 
driven by two complementary processes: growth in the ecology of 
forms of knowledge and the emergence of coordination mechanisms. 
Accordingly, it proposed the notion that the selection and formulation 
of medical problems is shaped by theoretical conjectures and practical 
problem-solving alike. It delved on the directionality of learning 
pathways across scientific and clinical practices by applying network 
analytical methods to a dataset of Glaucoma publications. Through the 
application of the Main Path algorithm we have mapped a cross 
section of important papers in this scientific medical community. The 
selection of papers captures and confirms the changing trajectory that 
has occurred in Glaucoma research over the past fifty years. We have 
been able to document the transition from a single cause paradigm 
(i.e. Intra Ocular Pressure) to a multi causal explanation of the disease 
and reflect on the fact that problem-finding and problem-solving are 
complementary processes. Therefore, while we claim that it is not 
possible to establish a priori any directionality in the dialogue 
between scientific and clinical domains, we propose an analytical 
route to disentangle the pathways of learning embedded in scientific 
problem-choice and problem-solving activities. 
The longitudinal analysis undertaken also enabled us to highlight 
the expansion of the ecology of scientific journals, and connect this to 
the growth of knowledge. In so doing it interprets the evolution of a de 
facto standard, namely the journal, which facilitates information 
exchange within and across scientific communities. We have also 
argued that their proliferation is one of the signatures of the 
emergence of new sub-specialization.  
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Overall the paper contributes to the general understanding of the 
medical innovation process. It supports the notion that knowledge 
coordination is a distributed process that cuts across and connects 
complementary realms encompassing the organization of scientific 
research, the design of regulatory rules, the evolution of communities 
of practitioners, the organization of patient care and the creation of 
new market processes. 
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